INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 151 filers reported holding INSMED INC in Q3 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,281 | +26.2% | 50,000 | 0.0% | 0.00% | +50.0% |
Q2 2023 | $1,015 | +22.1% | 50,000 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $831 | -57.5% | 50,000 | -49.3% | 0.00% | -60.0% |
Q4 2022 | $1,957 | -99.9% | 98,600 | 0.0% | 0.01% | -16.7% |
Q3 2022 | $2,143,000 | +9.4% | 98,600 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $1,958,000 | -13.4% | 98,600 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $2,260,000 | -41.6% | 98,600 | -30.6% | 0.01% | -33.3% |
Q4 2021 | $3,868,000 | +10.0% | 142,100 | +5.9% | 0.01% | -10.0% |
Q3 2021 | $3,515,000 | -10.2% | 134,200 | 0.0% | 0.01% | -9.1% |
Q2 2021 | $3,915,000 | -9.4% | 134,200 | 0.0% | 0.01% | -21.4% |
Q1 2021 | $4,322,000 | -1.2% | 134,200 | +2.7% | 0.01% | -12.5% |
Q4 2020 | $4,373,000 | +17.3% | 130,700 | +12.7% | 0.02% | -5.9% |
Q3 2020 | $3,728,000 | +688.2% | 116,000 | +347.9% | 0.02% | +466.7% |
Q3 2019 | $473,000 | -63.9% | 25,900 | -50.0% | 0.00% | -57.1% |
Q2 2019 | $1,311,000 | +79.3% | 51,800 | +54.6% | 0.01% | +75.0% |
Q1 2019 | $731,000 | +56.5% | 33,500 | -6.7% | 0.00% | +33.3% |
Q4 2018 | $467,000 | -36.1% | 35,900 | +7.2% | 0.00% | -25.0% |
Q3 2018 | $731,000 | -11.5% | 33,500 | -2.6% | 0.00% | -20.0% |
Q2 2018 | $826,000 | +9.0% | 34,400 | 0.0% | 0.01% | 0.0% |
Q1 2018 | $758,000 | +84.4% | 34,400 | -2.0% | 0.01% | +66.7% |
Q4 2017 | $411,000 | 0.0% | 35,100 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $411,000 | -32.3% | 35,100 | 0.0% | 0.00% | -40.0% |
Q2 2017 | $607,000 | +0.7% | 35,100 | 0.0% | 0.01% | -16.7% |
Q1 2017 | $603,000 | +17.5% | 35,100 | -7.9% | 0.01% | +20.0% |
Q4 2016 | $513,000 | +4.5% | 38,100 | +8.2% | 0.01% | 0.0% |
Q3 2016 | $491,000 | +41.1% | 35,200 | 0.0% | 0.01% | +25.0% |
Q2 2016 | $348,000 | +6.1% | 35,200 | +32.3% | 0.00% | 0.0% |
Q1 2016 | $328,000 | -44.3% | 26,600 | -15.3% | 0.00% | -42.9% |
Q4 2015 | $589,000 | +2.4% | 31,400 | +1.6% | 0.01% | 0.0% |
Q3 2015 | $575,000 | -19.4% | 30,900 | +5.8% | 0.01% | -12.5% |
Q2 2015 | $713,000 | +46.7% | 29,200 | +24.8% | 0.01% | +33.3% |
Q1 2015 | $486,000 | – | 23,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |